Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update

Regulus Therapeutics (RGLS) Misses Q4 EPS by 1c

March 2, 2017 4:11 PM EST

Regulus Therapeutics (NASDAQ: RGLS) reported Q4 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at less than $100 thousand versus $10.9 million last year,

Cash, cash equivalents and short-term investments were $76.1 million at December 31, 2016, compared with $115.3 million at December 31,... More